Support this
Research Program


Key Researcher

Allan Collins, MD, FACP

Allan Collins, MD, FACP, has over twenty years of experience in nephrology and ESRD treatment. His clinical experience and research have focused on acute and chronic care of ESRD patients and prospective and retrospective focused clinical studies on dialysis techniques and associated outcomes. He has also done extensive work with high-efficiency dialysis and therapy prescription, the technical elements of dialysis, billing systems of ICD-9 and CPT-4 claims elements, and computer systems and operations.

Suggested Links*

American Association of Kidney Patients

American Diabetes Association


*MMRF is not responsible for the content on external websites. The appearance of these links on the MMRF website does not constitute an endorsement by MMRF.

research banner

Home > Our Research > Chronic Disease

Chronic Disease

Chronic diseases are the leading cause of death in the United States. They result in long-term and permanent disability for millions of Americans, with serious quality-of-life consequences for them and their families, and with enormous economic consequences for individuals, health plans, and the country.

A division of the Minneapolis Medical Research Foundation, the Chronic Disease Research Group (CDRG) investigates public health issues related to chronic illness and its treatment. CDRG seeks to improve public health and to influence health policy, healthcare providers, and health plans by helping industry planners better understand and respond to patient needs.

CDRG was founded in 1995 as Nephrology Analytical Services. Under the leadership of MMRF investigator Allan J. Collins, MD, FACP, the research agenda has expanded beyond kidney disease to include other chronic conditions. Clinical specialists in cardiovascular disease, chronic kidney disease, dementia, diabetes, end-stage renal disease (ESRD), geriatrics, nephrology, and pharmacy work with epidemiologists and biostatisticians to analyze disease conditions and evaluate the effects of treatment on morbidity, survival, quality of life, and healthcare costs.